โ Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights ๐ข Company Q&A (465) ๐ ๏ธ Industry Q&A (98) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
Date | Press release |
---|---|
2025-05-30 05:45:00 | Levi & Korsinsky Reminds Shareholders Of A Lead Plaintiff Deadline Of June 3, 2025 In Cerevel Therapeutics Holdings, Inc. Lawsuit - Abbv New york , may 30, 2025 /prnewswire/ -- levi & korsinsky, llp notifies investors in cerevel therapeutics holdings, inc. (โcerevel therapeutics holdings, inc.โ or the โcompanyโ) (nyse: abbv) of a class action securities lawsuit. class definition: the lawsuit seeks to recover losses on behalf of cerevel therapeutics holdings, inc. investors who were adversely affected by alleged securities fraud. |
2025-05-29 12:22:00 | Contact The Gross Law Firm By June 3, 2025 Deadline To Join Class Action Against Cerevel Therapeutics Holdings, Inc.(abbv) New york, may 29, 2025 (globe newswire) -- the gross law firm issues the following notice to shareholders of cerevel therapeutics holdings, inc. (nyse: abbv). |
2025-05-29 05:45:00 | Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (abbv) Seeking Recovery For Investors - Contact The Gross Law Firm New york , may 29, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of cerevel therapeutics holdings, inc. (nyse: abbv). shareholders who purchased shares of abbv during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. |
2025-05-27 09:15:00 | Lost Money On Cerevel Therapeutics Holdings, Inc. (abbv)? Urged To Join Class Action Before June 3, 2025 - Contact Levi & Korsinsky New york, ny / access newswire / may 27, 2025 / if you suffered a loss on your cerevel therapeutics holdings, inc. (nyse:abbv) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=150335&wire=1&utm_campaign=22 or contact joseph e. levi, esq. |
2025-05-27 09:00:00 | Abbvie Features New Data Across Difficult-to-treat Solid Tumors And Blood Cancers At Asco 2025, Highlighting Breadth And Depth Of Its Oncology Portfolio -ย ย key oral presentations highlight new data from abbvieโs novel investigational antibody-drug conjugates (adcs) including telisotuzumab adizutecan (abbv-400, temab-a) in advanced non-small cell lung cancer (nsclc), abbv-706 in high-grade neuroendocrine neoplasms (nens) and pivekimab sunirine (pvek) in blastic plasmacytoid dendritic cell neoplasm (bpdcn). north chicago, ill. |
2025-05-27 07:30:00 |
|
2025-05-23 05:45:00 |
|
2025-05-22 13:47:00 |
|
2025-05-22 05:45:00 |
|
2025-05-21 13:20:00 |
|
2025-05-21 07:25:00 |
|
2025-05-20 05:45:00 |
|
2025-05-19 13:30:00 |
|
2025-05-19 13:04:00 |
|
2025-05-19 07:30:00 |
|

๐ฐ Browse additional press releases for AbbVie!
Sign up for free or log inโก Instantly access "The Checklist Value Investor โ A Smarter Way to Pick Stocks" โ free!